Incannex Healthcare develops combination drugs for sleep apnea and anxiety, based in Norwest, New South Wales. It last closed at $1.74 on Nov 17, down 9.84% on the day. IXHL reports earnings on Fri, Feb 12, 2027.
IXHL · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 34% below its 20 day and 65% below its 50 day average. It is 114% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 17), oversold. The nearest support is the 52 week low at $1.72, and the nearest resistance the Pivot at $1.76.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 8.9%/day
Key levels
$14.9152 week high+756.9%
$3.72200 day average+113.8%
$3.09100 day average+77.6%
$2.8750 day average+64.9%
$2.79Swing high (Oct 28)+60.3%
$2.3420 day average+34.5%
$1.81Pivot R1+4.0%
$1.76Pivot+1.1%
$1.74Last close
$1.7252 week low−1.1%
$1.70Pivot S1−2.3%
Indicators
RSI (14)
16.71
Oversold below 30
Oversold
MACD
-0.29
Below its signal line
Bearish
Stochastic
3.0
Near the bottom of its range
Oversold
ADX (14)
49.5
Strong downtrend
Williams %R
-98.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-149.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−30.3%
Change over 10 sessions
Bearish
ATR (14)
$0.15
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityLow, 35.4%/day
Key levels
$14.9152 week high+756.9%
$3.72200 day average+113.8%
$3.09100 day average+77.6%
$2.8750 day average+64.9%
$2.79Swing high (Oct 28)+60.3%
$2.3420 day average+34.5%
$1.81Pivot R1+4.0%
$1.76Pivot+1.1%
$1.74Last close
$1.7252 week low−1.1%
$1.70Pivot S1−2.3%
Indicators
RSI (14)
30.20
Weak, oversold below 30
Neutral
MACD
-0.78
Above its signal line
Bullish
Stochastic
2.3
Near the bottom of its range
Oversold
ADX (14)
10.1
No clear trend
Williams %R
-99.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-207.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−46.6%
Change over 10 sessions
Bearish
ATR (14)
$0.62
Typical daily range, 35.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IXHL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IXHL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow IXHL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How IXHL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IXHL is in one of them and how their past IXHL trades turned out.
Incannex Healthcare is a drug development company based in Norwest, New South Wales. It is developing combination medicines taken by mouth, along with a treatment that pairs synthetic psilocybin with psychological therapy. Its main development focus is a treatment for obstructive sleep apnea, and a second program targets generalized anxiety disorder. The company is at the clinical trial stage and aims to give patients treatment options where existing care falls short.